Use of live bacterial vaccine vectors for antigen delivery: potential and limitations.
about
Perspectives on the probiotic potential of lactic acid bacteria from African traditional fermented foods and beveragesCurrent Status of Veterinary VaccinesPresence of wild-type and attenuated Salmonella enterica strains in brain tissues following inoculation of mice by different routesConstruction of EGFP-tagged rBCG of E.tenella and distribution in chickens.Adjuvant effects for oral immunization provided by recombinant Lactobacillus casei secreting biologically active murine interleukin-1{beta}Lactobacillus plantarum producing a Chlamydia trachomatis antigen induces a specific IgA response after mucosal booster immunization.Oral spore vaccine based on live attenuated nontoxinogenic Bacillus anthracis expressing recombinant mutant protective antigen.Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccineMucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes.Assessment of 2 Salmonella enterica serovar Typhimurium-based vaccines against necrotic enteritis in reducing colonization of chickens by Salmonella serovars of different serogroups.CD8 T-cell induction against vascular endothelial growth factor receptor 2 by Salmonella for vaccination purposes against a murine melanomaAttenuation of bacterial virulence by quorum sensing-regulated lysis.Enhancement of Th1-biased protective immunity against avian influenza H9N2 virus via oral co-administration of attenuated Salmonella enterica serovar Typhimurium expressing chicken interferon-α and interleukin-18 along with an inactivated vaccine.Comparative immunological evaluation of recombinant Salmonella Typhimurium strains expressing model antigens as live oral vaccines.Heterologous expression of Brucella abortus GroEL heat-shock protein in Lactococcus lactisEngineered commensal bacteria as delivery systems of anti-infective mucosal protectants.Live bacteria as the basis for immunotherapies against cancer.A quorum sensing-based in vivo expression system and its application in multivalent bacterial vaccinePrevalence and significance of plasmid maintenance functions in the virulence plasmids of pathogenic bacteria.Immunogenicity of recombinant classic swine fever virus CD8(+) T lymphocyte epitope and porcine parvovirus VP2 antigen coexpressed by Lactobacillus casei in swine via oral vaccinationEvaluation of Salmonella enterica type III secretion system effector proteins as carriers for heterologous vaccine antigens.In Vivo Programmed Gene Expression Based on Artificial Quorum NetworksProtection against Foot-and-Mouth Disease Virus in Guinea Pigs via Oral Administration of Recombinant Lactobacillus plantarum Expressing VP1.Orally delivered malaria vaccines: not too hard to swallow.Bacillus subtilis as a tool for vaccine development: from antigen factories to delivery vectors.Beneficial effects of live and dead Salmonella-based vector strain on the course of colitis in mice.Induction of immune responses in mice after intragastric administration of Lactobacillus casei producing porcine parvovirus VP2 protein.Transfected Babesia bovis Expressing a Tick GST as a Live Vector Vaccine.Bacteria in gene therapy: bactofection versus alternative gene therapy.Formulation and delivery of vaccines: Ongoing challenges for animal management.Immunization with non-replicating E. coli minicells delivering both protein antigen and DNA protects mice from lethal challenge with lymphocytic choriomeningitis virustRNA modification by GidA/MnmE is necessary for Streptococcus pyogenes virulence: a new strategy to make live attenuated strains.Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment.Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA.An oral recombinant Salmonella enterica serovar Typhimurium mutant elicits systemic antigen-specific CD8+ T cell cytokine responses in miceOral vaccine delivery: can it protect against non-mucosal pathogens?Induction of immune responses in mice after oral immunization with recombinant Lactobacillus casei strains expressing enterotoxigenic Escherichia coli F41 fimbrial protein.Assessment of attenuated Salmonella vaccine strains in controlling experimental Salmonella Typhimurium infection in chickens.Immunogenic Properties of Lactobacillus plantarum Producing Surface-Displayed Mycobacterium tuberculosis Antigens.Harnessing the potential of bacterial ghost for the effective delivery of drugs and biotherapeutics.
P2860
Q26766691-14C1C5BE-6E29-4823-81BE-A99A5494FC31Q27480923-D8EDDDE9-6AEA-4C44-8729-935AE86C07A1Q33334033-E1DBC705-6D62-40A0-8E09-A5275D4D0708Q33419174-F80A5B77-E0F5-485C-AE4B-5E1FC6B8ED50Q33613453-74B5A860-F1A6-4F03-AEAA-89CDC58BCABCQ33632705-9F3675B3-84B9-4145-8068-77AEDF944E79Q33883273-37E646B1-0C9E-4510-91AF-8ADC2BD9C95BQ34120949-B28EF328-37F0-41A0-A2C0-4A4286EBC5DAQ34145098-F92A5951-DFB0-4264-BC8A-CA6F315B7740Q34171783-36BBBF8D-4905-4462-9125-6BAB60BF7901Q34236740-6B79943B-6CDA-4486-B7A1-0BDFC8D02138Q34281775-5D7F499B-146E-45BF-8593-19981B63B2B7Q34331463-DFDBDC33-D28F-470F-8C51-548CF44E4567Q34421752-3AE8C829-0D67-435C-816F-CF458C06E00FQ34557340-B128AB49-AA3B-44D5-992D-0055F4819B3BQ35042482-FB5C1E12-45A5-4207-BCE0-CE57F0BCAC34Q35193514-5AB662C0-D415-4D9B-9F55-BF65DAD40472Q35213546-3287347D-8CAA-46DB-9298-0805BFA76C8DQ35329047-1E2F7D5C-66E1-4604-AEA7-974EA2AAAF95Q35530213-E9C9963A-8AC3-4372-B0D4-9A7E49C877E9Q35805445-C252B2F2-9154-459A-9918-2E8BFE19CC7FQ35829353-7FC1B3BF-66C1-48CD-B0D4-363F4B9FAD3BQ35858585-9CE3B906-3B79-4B02-AB90-A19DFF1AE9FAQ35907014-3ADC303D-3DE2-4CDE-A845-E0FFA7E976C7Q36030835-4D994991-1DC1-4B16-84F7-E139A1CE52A0Q36097651-01ECE5DF-10C6-4A35-BBAC-379E157F8636Q36136940-AB50A22A-F0E1-4AD9-947E-6244B3FC9ECCQ36211840-A45A6E69-EB67-488D-BF1D-761276393328Q36257622-404D9653-7141-4875-A2C6-7A8D9E8D3D31Q36470265-37E7EE85-42E3-4186-812D-5F65E96F17ABQ36658309-2D6FAC3D-5055-4660-A506-8973D2C0CC49Q36747212-A4654B2C-B7B6-4CDF-A8A8-51DCB6C4433BQ36756869-084A5B6D-3CDD-434D-865E-593782010A2DQ37062098-5C0680BA-3A8A-425C-A38B-ABB6E86946DDQ37185975-0C5B9C00-CC69-4566-A7FF-DED58B068DA5Q37229915-CC5546CD-5D7C-4A21-B12D-744ADEDEFEDEQ37248099-013E26C3-334F-49E9-85F8-335E079D8AD0Q37425256-6AEA2D3A-4CFA-469A-9B71-7F9159031B26Q37546883-7D4EB633-18D6-47CC-B339-D2CB8A842C09Q37621279-B0EA4254-2321-4F2B-AF85-022C0711B499
P2860
Use of live bacterial vaccine vectors for antigen delivery: potential and limitations.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Use of live bacterial vaccine vectors for antigen delivery: potential and limitations.
@ast
Use of live bacterial vaccine vectors for antigen delivery: potential and limitations.
@en
type
label
Use of live bacterial vaccine vectors for antigen delivery: potential and limitations.
@ast
Use of live bacterial vaccine vectors for antigen delivery: potential and limitations.
@en
prefLabel
Use of live bacterial vaccine vectors for antigen delivery: potential and limitations.
@ast
Use of live bacterial vaccine vectors for antigen delivery: potential and limitations.
@en
P1433
P1476
Use of live bacterial vaccine vectors for antigen delivery: potential and limitations.
@en
P2093
P304
P356
10.1016/S0264-410X(00)00354-6
P407
P577
2001-02-01T00:00:00Z